Total planned funding: $368,196,973
Clear active filters
Implementing Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $144,596,064 |
Uganda | $40,271,175 |
Zimbabwe | $35,485,501 |
Nigeria | $33,487,333 |
Ethiopia | $23,200,906 |
Côte d'Ivoire | $18,121,786 |
Zambia | $10,906,079 |
Dominican Republic | $9,048,443 |
Kenya | $7,691,497 |
Cameroon | $7,217,478 |
Lesotho | $6,739,199 |
Mozambique | $6,378,109 |
Tanzania | $4,731,276 |
Guyana | $2,800,000 |
Ukraine | $2,800,000 |
Vietnam | $2,558,075 |
Malawi | $2,318,586 |
Namibia | $1,867,441 |
Botswana | $1,666,000 |
Ghana | $1,497,998 |
Haiti | $1,482,716 |
Indonesia | $1,450,000 |
Caribbean Region | $1,365,000 |
Cambodia | $458,311 |
Eswatini | $50,000 |
Asia Regional Program | $8,000 |
Angola | $0 |
Organizational Types
Implementing Agency | $368,196,973 |
Program Areas
Treatment | $102,084,010 |
Care | $94,415,589 |
Prevention | $83,770,074 |
Governance and Systems | $40,651,449 |
Testing | $24,050,565 |
Budget Codes
HTXS: Treatment: Adult Treatment | $91,556,343 |
HBHC: Care: Adult Care and Support | $39,907,358 |
HKID: Care: Orphans and Vulnerable Children | $31,221,171 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $30,224,162 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $24,204,233 |
HVCT: Testing: HIV Testing and Counseling | $24,050,565 |
HVOP: Sexual Prevention: Other Sexual Prevention | $20,460,370 |
HVTB: Care: TB/HIV | $17,679,403 |
OHSS: Health Systems Strengthening | $15,816,571 |
HLAB: Laboratory Infrastructure | $12,694,184 |
HVSI: Strategic Information | $12,140,694 |
PDTX: Treatment: Pediatric Treatment | $9,621,454 |
PDCS: Care: Pediatric Care and Support | $5,607,657 |
HMBL: Biomedical Prevention: Blood Safety | $5,092,669 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,454,349 |
HTXD: Treatment: ARV Drugs | $906,213 |
HMIN: Biomedical Prevention: Injection Safety | $758,291 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $576,000 |
Top Partner Programs
TB/HIV Care Association:
$46,638,601
View countries
University of the Witwatersrand:
$45,876,611
View countries
John Snow, Inc:
$36,729,484
View countries
Caritas Internationalis:
$25,914,497
View countries